GlassScriptPhysician profile
Emily J Ernst
NPI 1407019839
$2,048.80
in general payments reported to CMS, 2019-2025
35 companies · $234 in 2025
The $234 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $251 · 2020: $294 · 2021: $350 · 2022: $324 · 2023: $362 · 2024: $233 · 2025: $234.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $829.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $829.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $268.72 | 2019-2022 | |
| Paratek Pharmaceuticals, INC. | $239.27 | 2022-2025 | Nuzyra |
| Smith+Nephew, INC. | $237.15 | 2019-2023 | Bone Anchors With Arthroscopic Delivery System |
| Stryker Corporation | $232.68 | 2020-2025 | Augment Injectable, Prostep, Variax |
| Organogenesis INC. | $195.73 | 2020-2025 | Apligraf, Puraply Franchise |
| Orthofix Medical, INC. | $116.69 | 2020-2025 | Physio-Stim |
| Medtronic, INC. | $85.89 | 2022-2024 | Intellis Adaptivestim |
| Access Pro Medical, LLC | $58.09 | 2023 | Matriderm |
| Bioventus LLC | $55.12 | 2021-2022 | |
| Mimedx Group, INC. | $49.42 | 2024-2025 | |
| Nabriva Therapeutics, Plc | $39.42 | 2022 | |
| Melinta Therapeutics, LLC | $36.48 | 2019 | |
| Dynasplint Systems INC. | $35.37 | 2019 | |
| Advanced Oxygen Therapy INC. | $35.15 | 2023 | Topical Oxygen Chamber For Extremities |
| Alfasigma USA, INC. | $30.34 | 2021 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $30.12 | 2019 | |
| Zimvie INC. | $29.47 | 2022-2023 | |
| Heron Therapeutics, INC. | $28.19 | 2021 | |
| Kerecis Limited | $17.89 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Biowound Solutions, INC. | $17.50 | 2025 | Bio-Connekt |
| Reprise Biomedical, INC. | $16.44 | 2025 | Miro3d |
| Wright Medical Technology, INC. | $16.36 | 2019 | |
| Djo, LLC | $16.16 | 2019 | |
| Zimmer Biomet Holdings, INC. | $15.99 | 2020 | |
| Innovation Technologies INC | $15.83 | 2025 | Irrisept |
| Tactile Systems Technology INC | $14.29 | 2020 | |
| Avita Medical Americas, LLC | $14.21 | 2024 | |
| Celularity INC. | $14.00 | 2019 | |
| Next Science LLC | $13.86 | 2023 | Surgx, Blastx, Xperience |
| Treace Medical Concepts, INC. | $13.69 | 2022 | |
| Grt US Holding, INC. | $13.26 | 2021 | |
| Avanos Medical | $11.99 | 2021 | |
| Embody, INC. | $11.64 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $11.30 | 2019 | |
| Abbvie INC. | $11.09 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Ernst listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.